Fenofibrate in primary sclerosing cholangitis; a randomized, double‐blind, placebo‐controlled trial

Fenofibrate in primary sclerosing cholangitis; a randomized, double‐blind, placebo‐controlled trial

Abstract Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease with no medical treatment proven to improve survival and postpone liver transplantation. Previous studies have shown the effectiveness of fibrates in primary biliary cholangitis. The current study prospectively eval...

Full description

Bibliographic Details
Main Authors: Behzad Hatami, Mozhde Mosala, Amir Hossein Hassani, Mohammad Javad Ehsani Ardakani, Samira Gholami, Mohammad Reza Zali
Format: Article
Language:English
Published: Wiley 2022-08-01
Series:Pharmacology Research & Perspectives
Subjects:
alkaline phosphatase
cholangitis
cholestasis
fenofibrate
liver failure
PPAR alpha
Online Access:https://doi.org/10.1002/prp2.984

Internet

https://doi.org/10.1002/prp2.984

Similar Items